Cidara Therapeutics Highlights New Data from Multiple Rezafungin Studies Presented at ECCMID 2019

 

Lotus On Water Presents "Celebrating Wind and Water" in The Netherlands

 

Dutch Supreme Court Rules for Chevron in Ecuador Dispute

 

97% of Gemalto shares have been tendered to the Thales offer

 

Korian Accelerates Its Diversification into Specialised Care Services and Enters the Dutch Market

 

Interxion Schedules First Quarter 2019 Earnings Announcement

 

MEDIA ALERT: Marketing Evolution CEO to Speak at SAP’s European Executive Digital Exchange

 

QIAGEN N.V. to Report First Quarter 2019 Results

 

Shionogi Announces Data Demonstrating Potent in Vitro Activity of Cefiderocol against the Most Critical Priority Gram-Negative Bacterial Pathogens

 

Results of Phase 3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam) versus Meropenem for Treatment of Adult Patients with Ventilated Nosocomial Pneumonia (VNP) to be Presented at ECCMID 2019